A Phase 3 interventional study of Stannous Fluoride and Sodium Monofluorophosphate in Dentine Hypersensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in Ireland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-06.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Dentin Sensitivity by GlaxoSmithKline — none open to participants now, none under way, none of them phase 3. Dentin Sensitivity · GlaxoSmithKline.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, this one is the 20th largest by enrollment, is one of 4 that started in 2012, is one of 5 in phase 3, and was the 24th registered.
290 studies on the registry are indexed under Dentin Sensitivity; 48 are open to participants now.
Browse Dentin Sensitivity studies →None of the 28 studies in Dentin Sensitivity by GlaxoSmithKline is open now. The open studies under Dentin Sensitivity, anywhere →
Of the 19 Dentin Sensitivity studies recruiting now, 6 (32%) set no upper age limit and 12 (63%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2012.
This study's enrollment of 120 is above the median of 60 across 281 interventional studies indexed under Dentin Sensitivity.
Median enrollment 164 across the 28 interventional studies. Of the 27 that completed or were terminated, 27 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A randomised, examiner blind, two treatment arm, stratified, parallel design, single-site study in subjects with at least two sensitive teeth to compare the efficacy of a test dentifrice against that of a control dentifrice in reducing dentinal hypersensitivity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Toothpaste
Drug: Stannous Fluoride
Toothpaste
Drug: Sodium Monofluorophosphate
Test dentifrice, participants will brush each of the 2 selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute.
Control dentifrice, participants will brush the whole mouth thoroughly for at least 1 minute.
Change From Baseline in Schiff Sensitivity Score on Day 14
Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.
Time frame: Baseline, Day 14
Change From Baseline in Schiff Sensitivity Score on Post First Brushing (After 5 Minutes) and Day 3
Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity.
Time frame: Baseline, post first brushing (after 5 minutes) and Day 3
Change From Baseline in Tactile (Yeaple) Pain Threshold on Post First Brushing (After 5 Minutes), Day 3 and Day 14
Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.
Time frame: Baseline, post first brushing (after 5 minutes), Day 3 and Day 14
Participants were recruited at a single center in Ireland.
| Milestone | Experimental Dentifrice | Reference Dentifrice |
|---|---|---|
| Started | 60 | 60 |
| Completed | 59 | 59 |
| Not completed | 1 | 1 |
| Withdrew: Adverse event | 1 | 1 |
Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.
| score on a scale | Experimental Dentifrice | Reference Dentifrice |
|---|---|---|
| At Baseline | 2.51 ± 0.437 | 2.51 ± 0.446 |
| At Day 14 | 1.16 ± 0.774 | 1.35 ± 0.901 |
| Change from Baseline on Day 14 | -1.35 ± 0.727 | -1.16 ± 0.762 |
Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity.
| score on a scale | Experimental Dentifrice | Reference Dentifrice |
|---|---|---|
| After 5 minutes of brushing | 1.73 ± 0.826 | 1.92 ± 0.737 |
| Change after 5 minutes of brushing | -0.78 ± 0.660 | -0.59 ± 0.571 |
| On Day 3 | 1.63 ± 0.784 | 1.77 ± 0.785 |
| Change from baseline on Day 3 | -0.88 ± 0.658 | -0.74 ± 0.568 |
Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.
| gram (g) | Experimental Dentifrice | Reference Dentifrice |
|---|---|---|
| At Baseline | 10.8 ± 2.29 | 11.5 ± 2.65 |
| After 5 minutes of brushing | 16.5 ± 13.82 | 16.7 ± 11.19 |
| Change after 5 minutes of brushing | 5.7 ± 13.45 | 5.2 ± 10.93 |
| On Day 3 | 18.4 ± 17.32 | 18.6 ± 16.73 |
| Change from baseline on Day 3 | 7.5 ± 17.73 | 7.1 ± 16.48 |
| On Day 14 | 25.3 ± 22.64 | 23.8 ± 22.33 |
| Change from baseline on Day 14 | 14.6 ± 22.67 | 12.3 ± 21.68 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Experimental Dentifrice | 0/60 (0%) | 0/60 (0%) | 9/60 (15%) |
| Reference Dentifrice | 0/60 (0%) | 0/60 (0%) | 8/60 (13.3%) |
| Event | Experimental Dentifrice | Reference Dentifrice |
|---|---|---|
| Sensitivity of TeethGastrointestinal disorders | 5/60 | 0/60 |
| Dry MouthGastrointestinal disorders | 0/60 | 2/60 |
| Gingival BleedingGastrointestinal disorders | 0/60 | 1/60 |
| GingivitisGastrointestinal disorders | 1/60 | 0/60 |
| Mouth UlcerationGastrointestinal disorders | 0/60 | 1/60 |
| Oral HerpesInfections and infestations | 0/60 | 1/60 |
| Tooth InjuryInjury, poisoning and procedural complications | 1/60 | 0/60 |
| ToothacheGastrointestinal disorders | 1/60 | 0/60 |
| Axillary CandidiasisInfections and infestations | 1/60 | 0/60 |
| Axillary PainGeneral disorders | 1/60 | 0/60 |
| Age, Continuous(Years) | Experimental Dentifrice | Reference Dentifrice | Total |
|---|---|---|---|
| Mean | 28.4 ± 12.85 | 30.7 ± 11.66 | 29.5 ± 12.27 |
| Sex: Female, Male(Participants) | Experimental Dentifrice | Reference Dentifrice | Total |
|---|---|---|---|
| Female | 35 | 40 | 75 |
| Male | 25 | 20 | 45 |
| Ethnicity (NIH/OMB)(Participants) | Experimental Dentifrice | Reference Dentifrice | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 1 | 2 |
| Not Hispanic or Latino | 59 | 59 | 118 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Experimental Dentifrice | Reference Dentifrice | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 1 | 1 |
| White | 60 | 59 | 119 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
Ran from Mar 2012 to primary completion in Jun 2012, 3 months.
Results were first posted in Apr 2017, 4 years 10 months after primary completion.
Of 13 phase 3 interventional studies under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tin Fluorides